# Scopus BioPharma Inc. (SCPS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SCPS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 0 | $ -5.48M | $ -1.91M | $ 0 | $ -9.45M |
| 2022 | $ 0 | $ -12.97M | $ -10.81M | $ 0 | $ -6.56M |
| 2021 | $ 0 | $ -32.04M | $ -15.96M | $ 0 | $ 4.02M |
| 2020 | $ 0 | $ -13.84M | $ -3.22M | $ 2.28M | $ -1.83M |
| 2019 | $ 0 | $ -3.47M | $ -2.74M | $ 0 | $ -82.9K |
| 2018 | $ 0 | $ -362.8K | $ -426.1K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -1.16 |
| Current Ratio | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/SCPS.md)
- [Charts](https://sponda.capital/en/SCPS/charts.md)
- [Compare](https://sponda.capital/en/SCPS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.